| Issue |
Section |
Title |
File |
| Vol 81, No 4 (2009) |
Editorial |
HCV genome variability in acute and chronic viral hepatitis C |
|
| Vol 84, No 11 (2012) |
Editorial |
Immunogenetic predictors of a rapid virologic response to antiviral therapy in patients with chronic hepatitis C |
|
| Vol 84, No 11 (2012) |
Editorial |
Long-term entecavir efficacy retention in the treatment of chronic hepatitis B with an outcome to hepatic cirrhosis caused by its resistant virus strain |
|
| Vol 85, No 12 (2013) |
Editorial |
The burden of viral hepatitides in the Russian Federation and ways of its reduction for the long term (in case of hepatitis C) |
|
| Vol 86, No 10 (2014) |
Editorial |
The problem of viral hepatitis C in the Russian Federation |
|
| Vol 88, No 5 (2016) |
Editorial |
Analysis of ineffective antiviral therapy with pegylated interferon and ribavirin in a patient with chronic hepatitis C infected with HCV genotype 2 |
(Rus)
|
| Vol 88, No 6 (2016) |
Editorial |
The efficiency of antiviral therapy in patients with chronic hepatitis C infected with hepatitis C virus recombinants |
(Rus)
|
| Vol 88, No 11 (2016) |
Editorial |
Possibilities of using cepeginterferon alpha-2b in double (cepeginterferon alfa-2b and ribavirin) and triple (simeprevir, cepeginterferon alpha-2b, and ribavirin) antiviral therapy regimens for chronic hepatitis C. A review of clinical trials and experience of everyday clinical practice |
(Rus)
|
